use, the risk classification, and the lifecycle of the device.

The GSPR consists of several essential categories, including:

• General requirements: Addressing both the safety and performance of the device must be demonstrated through comprehensive clinical data.
• Design and manufacturing: Establishing quality management systems and standard operating procedures that adhere to ISO standards.
• Clinical evaluation: Ensuring systematic appraisal of a device’s performance based on clinical evidence throughout its lifecycle.
• Post-market surveillance: Highlighting the need for manufacturers to continuously monitor device performance once it is on the market.

Understanding the full scope of GSPR is the first critical step in compliance. Stakeholders must thoroughly review each requirement to determine how their specific device aligns with these obligations.

Step 2: Preparing the Device for GSPR Evaluation

Following a preliminary understanding of the GSPR, the next step involves preparing your device for evaluation. This stage lays the groundwork for product compliance and engagement with a Notified Body:

• Device Classification:

  Assign the appropriate classification to your medical device. The classification impacts the regulatory pathway and the depth of required documentation:

  • Class I: Low-risk devices; often subjected to self-certification.
  • Class IIa/IIb: Moderate to high-risk devices; require Notified Body intervention.
  • Class III: High-risk devices; necessitate rigorous review, including a full quality management system audit.

• Quality Management System (QMS):

  Ensure the establishment of a robust QMS compliant with ISO13485. This is crucial for meeting GSPR documentation requirements. Key elements of the QMS include:

  • Document control procedures.
  • Management responsibility and commitment.
  • Resource management and training programs.
  • Process validation and verification methods.

• Risk Management:

  The implementation of ISO 14971 for risk management processes is a vital step for GSPR compliance. Proper risk analysis, evaluation, control, and monitoring must be documented comprehensively.

Conducting thorough evaluations and adhering to the defined QMS protocols yields documentation that will be necessary for the subsequent GSPR evaluations.

Step 3: Conducting Clinical Evaluation as per GSPR

Under GSPR requirements, a clinical evaluation is mandatory for demonstrating device performance and safety. This evaluation must be a systematic and planned approach to collecting clinical data, and it can typically leverage existing data, peer-reviewed literature, and post-market data from similar devices:

• Clinical Evidence Requirements:

  Identify the clinical evidence necessary to demonstrate compliance with GSPR. This focuses on:

  • Direct clinical investigations.
  • Analysis of clinical literature.
  • Post-market clinical follow-up data.

• Creating a Clinical Evaluation Plan (CEP):

  Draft a comprehensive Clinical Evaluation Plan that outlines the objectives, method, timeline, and resources required for the evaluation process. Ensure that the CEP aligns with Article 61 of the MDR.

• Implementation of Clinical Evaluation:

  Carry out the clinical evaluation according to your CEP, ensuring that data collection, analysis, and reporting are completed accurately. This will necessitate collaboration across teams to ensure that insights align with overarching regulatory expectations.

Your clinical evaluation is vital, as it will be a cornerstone document that verifies your compliance with the GSPR. The results should be meticulously documented, as they contribute substantially to your device’s technical file.

Step 4: Engaging with a Notified Body for Conformity Assessment

Post Clinical Evaluation, the next phase requires engaging with a Notified Body for the conformity assessment of your device. This process is essential for compliance under the MDR:

• Selecting the Right Notified Body:

  Choose a Notified Body that is designated for your specific device classification and is authorized to assess conformity for EU MDR compliance. Factors to consider include:

  • Notified Body’s scope of designation.
  • Previous experience with similar devices.
  • The Body’s reputation and feedback from other manufacturers.

• Prepare for Notified Body Audit:

  In preparation for the Notified Body audit, compile all necessary documentation and data, including but not limited to:
  – The Technical Documentation, which should encompass the results from risk assessment, clinical evaluation, and performance data.
  – The QMS documentation outlined in accordance with ISO 13485.
  – Evidence of compliance with GSPR outlined in Annex II of the MDR.

• Conformity Assessment Process:

  The Notified Body will conduct a thorough review through an assessment process that typically includes:
  – Documentation review and evaluation of compliance.
  – On-site inspection for manufacturing practices and ISO compliance.
  – Issuance of a Declaration of Conformity upon successful assessment.

This stage is critical as the outcome determines if your device can enter the EU market successfully. It is important to document all interactions with your Notified Body meticulously, as this will aid in future audits and inspections.

Step 5: Preparing and Submitting the Technical Documentation

The Technical Documentation, often called the Technical File or Design Dossier, is crucial for demonstrating GSPR compliance and must be submitted to your Notified Body:
The structure of the Technical Documentation typically includes:

• General Device Information:

  Documentation should include device description, intended use, and classification. This gives context to the GSPR requirements and clinical evaluation data.

• Performance and Safety Data:

  Compile data supporting the device’s performance claims, including:

  • Clinical evaluation outcomes.
  • Risk management documentation.
  • Manufacturing process details, including validation and process controls.

• Quality Management System Documentation:

  Include a detailed QMS documentation that illustrates compliance with ISO 13485. This involves several management procedures, control mechanisms for supplier management, and product realization processes.

Additional components may include labeling requirements, user manuals, and a post-market surveillance plan. It is essential to ensure that your Technical Documentation is both comprehensive and transparent, as this will be reviewed extensively during the Notified Body evaluation.

Step 6: EUDAMED Registration and Post-Market Surveillance Obligations

Once the Technical Documentation has been successfully submitted and your device has received the CE mark, you must ensure that the device is registered in the European Database on Medical Devices (EUDAMED):
EUDAMED acts as a centralized repository, allowing for enhanced transparency and traceability:

• Device Registration in EUDAMED:

  Register the medical device in EUDAMED databases according to the mandated timelines following device launch to facilitate post-market surveillance activities. Registration includes:

  • Device identification information.
  • Manufacturer details.
  • Notified Body particulars.

• Post-Market Surveillance Plan:

  Establish a Post-Market Surveillance (PMS) system to continually monitor the safety and performance of your device in real-world use. Key components of the PMS include:

  • Regular collection and analysis of clinical data.
  • Field safety corrective actions in case of device incidents.
  • Periodic Safety Update Reports (PSURs) as mandated by the regulatory bodies.

• Continuous Improvement and Updates:

  Implement feedback systems that integrate findings from post-market data into future product iterations and ensure continuous improvement of the device.

Maintaining compliance with GSPR does not cease once the device is on the market. Regular updates to regulatory documentation and a proactive approach to post-market surveillance are essential to ensure ongoing compliance with EU MDR obligations.

Conclusion

In conclusion, achieving compliance with GSPR under the EU MDR regulatory framework requires thorough planning, documentation, and continuous engagement with both the Notified Bodies and regulatory bodies. By following the outlined steps—including understanding GSPR, preparing clinical evaluations, engaging with Notified Bodies, and implementing robust post-market surveillance systems—organizations can facilitate compliance and streamline market entry for their medical devices. Continuous adherence to these regulations underscores the importance of safety and effectiveness in medical devices across the EU market.

For industry stakeholders involved in FDA combination product consulting, familiarity with the EU MDR’s GSPR requirements can enhance understanding and harmonization of regulatory strategies across different regions, optimizing overall product development timelines.